Skip to content
PubMed This is a summary of 40 peer-reviewed journal articles Updated
Neurology · DYRK1A-Related Intellectual Developmental Disorder

DYRK1A Syndrome: A Patient Guide

At a Glance

DYRK1A syndrome is a rare genetic condition caused by loss of one working copy of the DYRK1A gene. It commonly causes microcephaly, developmental and speech difficulties, and movement or seizure problems; early communication tools and multidisciplinary therapies can support independence.

DYRK1A syndrome, also known as DYRK1A-related intellectual developmental disorder (historically called MRD7), is a rare genetic condition that significantly impacts a child’s neurological and physical development [1][2]. It is caused by haploinsufficiency of the DYRK1A gene, which means that one of the two copies of the gene is either missing or not functioning correctly [2][3]. Because this gene is essential for proper brain growth and the way neurons communicate, its absence leads to a specific set of developmental challenges that often appear early in infancy [4][1].

In most families, the diagnosis is identified through advanced genetic testing after parents or doctors notice a “core triad” of clinical features. This triad consists of microcephaly (a head size that is smaller than expected), significant developmental delays or intellectual disability, and a profound difficulty with spoken language [4][1]. While the severity of these features varies from one child to another, the struggle with communication is often the most significant hurdle. Many children find that while their receptive language (understanding) can be a relative strength, the physical act of speaking is highly complex due to apraxia (difficulty planning speech movements) or dysarthria (a motor-speech disorder that may involve muscle weakness, incoordination, or abnormal tone) [5].

Beyond the core symptoms, children with DYRK1A syndrome often face a variety of associated physical and neurological challenges. Many infants experience early feeding difficulties and slow weight gain, sometimes preceded by growth restriction before birth [6][7]. As they begin to move and walk, they may demonstrate ataxia (a lack of coordination) or a broad-based gait, where they walk with their feet wide apart for stability [1][6]. Additionally, a significant number of children—between one-third and two-thirds—will experience seizures, which may first appear as febrile seizures triggered by a fever during infancy [8][5].

While DYRK1A syndrome is a lifelong condition, the outlook for a child’s access and participation in daily life is improved by a proactive and multidisciplinary approach to care. This includes assembling a team of specialists—such as neurologists, geneticists, and therapists—who focus on managing symptoms and building functional skills [2][9]. One of the most impactful interventions is the early introduction of Augmentative and Alternative Communication (AAC), which provides children with tools like picture boards or speech-generating tablets to express themselves before or instead of verbal speech [5]. Physical and occupational therapies also play a vital role in helping children navigate their world with greater balance and independence [2].

Receiving a diagnosis of a rare condition can be overwhelming, but it also provides a framework for understanding your child’s needs. This guide is designed to supplement the care from your child’s clinicians and empower you with evidence-based information so you can advocate for the specialized screenings, therapies, and support your child needs. By understanding the unique way your child’s brain and body develop, you can move toward a future focused on their strengths, their progress, and their ability to connect with the world around them [10][5].

Common questions in this guide

What are the main symptoms of DYRK1A syndrome?
The core features are a smaller-than-expected head size (microcephaly), developmental delay or intellectual disability, and major difficulty with spoken language. Children may also have feeding and growth problems, coordination or walking differences, and seizures, but the pattern and severity vary.
What causes DYRK1A syndrome, and is it inherited?
DYRK1A syndrome occurs when one of the two copies of the DYRK1A gene is missing or does not work correctly. A genetic report can show whether the change is a deletion or a new change that arose in the child; a geneticist or genetic counselor can explain what it means for family members.
How is DYRK1A syndrome diagnosed?
Doctors usually suspect it when a child has the characteristic combination of microcephaly, developmental difficulties, and severe spoken-language impairment. Advanced genetic testing is used to confirm a change affecting the DYRK1A gene, while the clinical team also evaluates movement, feeding, growth, and seizures.
How can my child communicate if speaking is difficult?
Augmentative and alternative communication (AAC) can give a child ways to express needs before or instead of spoken language. Picture boards, gestures, and speech-generating tablets may be considered with the child’s clinicians and therapists, and understanding language may be stronger than spoken expression.
What treatments and therapies help children with DYRK1A syndrome?
Care is usually multidisciplinary, with neurologists, geneticists, and therapists working together to manage symptoms and build functional skills. Physical and occupational therapy can support balance, movement, and independence, while AAC supports communication.
How common are seizures in DYRK1A syndrome?
Seizures occur in about one-third to two-thirds of children with DYRK1A syndrome. They may first appear as febrile seizures during infancy, so families should ask their clinician which signs to watch for and what to do if a seizure occurs.
What monitoring should my child receive after a DYRK1A syndrome diagnosis?
The care team may track head circumference, weight, growth, development, communication, movement, and seizures over time. Families can also ask when a comprehensive eye exam is appropriate and whether condition-specific growth charts should be used alongside standard charts.

Get notified when new evidence is published on Neurodevelopmental disorder with microcephaly, impaired language, and gait abnormalities.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies.

    Ji J, Lee H, Argiropoulos B, et al.

    European journal of human genetics : EJHG 2015; (23(11)):1473-81 doi:10.1038/ejhg.2015.71.

    PMID: 25944381
  2. 2

    DYRK1A pathogenic variants in two patients with syndromic intellectual disability and a review of the literature.

    Meissner LE, Macnamara EF, D'Souza P, et al.

    Molecular genetics & genomic medicine 2020; (8(12)):e1544 doi:10.1002/mgg3.1544.

    PMID: 33159716
  3. 3

    Identification of two novel and one rare mutation in DYRK1A and prenatal diagnoses in three Chinese families with intellectual Disability-7.

    Huang C, Luo H, Zeng B, et al.

    Frontiers in genetics 2023; (14()):1290949 doi:10.3389/fgene.2023.1290949.

    PMID: 38179410
  4. 4

    Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A.

    Bronicki LM, Redin C, Drunat S, et al.

    European journal of human genetics : EJHG 2015; (23(11)):1482-7 doi:10.1038/ejhg.2015.29.

    PMID: 25920557
  5. 5

    Social motivation a relative strength in DYRK1A syndrome on a background of significant speech and language impairments.

    Morison LD, Braden RO, Amor DJ, et al.

    European journal of human genetics : EJHG 2022; (30(7)):800-811 doi:10.1038/s41431-022-01079-w.

    PMID: 35437318
  6. 6

    Case report of novel DYRK1A mutations in 2 individuals with syndromic intellectual disability and a review of the literature.

    Luco SM, Pohl D, Sell E, et al.

    BMC medical genetics 2016; (17()):15 doi:10.1186/s12881-016-0276-4.

    PMID: 26922654
  7. 7

    Growth charts in DYRK1A syndrome.

    Lanvin PL, Goronflot T, Isidor B, et al.

    American journal of medical genetics. Part A 2024; (194(1)):9-16 doi:10.1002/ajmg.a.63412.

    PMID: 37740550
  8. 8

    Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID.

    van Bon BW, Coe BP, Bernier R, et al.

    Molecular psychiatry 2016; (21(1)):126-32 doi:10.1038/mp.2015.5.

    PMID: 25707398
  9. 9

    Ocular Phenotype Associated with DYRK1A Variants.

    Méjécase C, Way CM, Owen N, Moosajee M

    Genes 2021; (12(2)) doi:10.3390/genes12020234.

    PMID: 33562844
  10. 10

    Characterization of phenotypic range in DYRK1A haploinsufficiency syndrome using standardized behavioral measures.

    Fenster R, Ziegler A, Kentros C, et al.

    American journal of medical genetics. Part A 2022; (188(7)):1954-1963 doi:10.1002/ajmg.a.62721.

    PMID: 35285131

This page is for informational purposes only and does not constitute medical advice. Your child’s neurologist, geneticist, and therapy team should interpret genetic results and tailor monitoring and support.